Key details
Phase
Early testing / Safety & dosing
Sponsor
University of North Texas Health Science Center
Collaborators
American Heart Association
Enrollment target
~72 participants
Primary completion
June 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
55 Years – 80 Years
Last updated December 2023